This corresponded to 5% of all alternatively spliced genes upon hnRNPM loss (Fig. 5F, 1.71-fold over enrichment, p value = 0.011, hypergeometric test), indicating that hnRNPM was likely involved in the splicing of known cancer-associated genes. The gene discussed is HNRNPM; the disease is cancer.